Form 4: Tempus AI General Counsel Sells Over 1,400 Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Andrew Polovin, Executive Vice President and General Counsel of Tempus AI, Inc., reported the sale of 1,423 shares of Class A Common Stock for approximately $102,640, executed under a Rule 10b5-1 trading plan.
Summary
- Andrew Polovin, EVP and General Counsel of Tempus AI, Inc. (TEM), reported a transaction involving the company's Class A Common Stock.
- On June 16, 2025, Mr. Polovin disposed of 1,423 shares of Class A Common Stock.
- The shares were sold at a price of $72.13 per share.
- The total value of the shares sold was approximately $102,640.
- Following this transaction, Mr. Polovin beneficially owns 137,454 shares of Class A Common Stock.
- The transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Polovin on September 6, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it's an insider sale, it was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned liquidity event rather than a reaction to negative company news. The amount sold is also relatively small compared to the total shares beneficially owned.
Positives
- The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a reaction to recent company performance or news, which can mitigate negative market perception of insider selling.
Negatives
- An insider sale, even if pre-planned, represents a reduction in direct ownership by a key executive, which some investors might interpret as a lack of confidence, although this is less likely with a 10b5-1 plan.
Risks
- While the sale was pre-planned, a consistent pattern of insider selling by multiple executives could potentially signal underlying concerns about future company performance or valuation, though this single transaction does not indicate such a pattern.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing is a standard disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape within the AI or healthcare technology sectors. It reflects an individual executive's personal financial planning.
Stakeholder Impact
- Shareholders: The sale represents a minor dilution of outstanding shares and a reduction in direct insider ownership. Given the small volume and 10b5-1 plan, the direct impact on share price or investor confidence is likely minimal.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Date the Rule 10b5-1 trading plan was adopted by Andrew Polovin. |
| 06/16/2025 | Date of the reported transaction (sale of Class A Common Stock). |
| 06/18/2025 | Date the Form 4 filing was signed by Andrew Polovin. |
Keywords
Tempus AI, TEM, Insider Sale, Form 4, Andrew Polovin, Stock Transaction, Rule 10b5-1 Plan, Executive Stock Sale, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.